Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Bausch Health Companies Inc. (BHC) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Bausch Health Companies Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 885590.
Total stock buying since 2015: $641,405,513.
Total stock sales since 2015: $1,482,479,792.
Total stock option exercises since 2015: $7,823,862.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 44,316,834 | $369,628,557 | 15,912 | $121,885 | 0 | $0 |
| 2024 | 0 | $0 | 20,123 | $148,568 | 0 | $0 |
| 2023 | 0 | $0 | 7,240 | $60,022 | 0 | $0 |
| 2022 | 0 | $0 | 35,842 | $842,627 | 729,638 | $0 |
| 2021 | 71,400 | $1,738,616 | 28,037 | $889,405 | 394,070 | $0 |
| 2020 | 5,965,143 | $101,782,769 | 1,104,879 | $21,326,840 | 192,904 | $2,169,350 |
| 2019 | 90,703 | $2,059,536 | 18,159 | $410,390 | 0 | $0 |
| 2018 | 7,347,069 | $114,940,631 | 7,086,575 | $109,324,388 | 0 | $0 |
| 2017 | 3,418,216 | $38,420,557 | 18,458,648 | $204,211,676 | 0 | $0 |
| 2016 | 215,000 | $5,214,810 | 3,476,690 | $51,628,846 | 0 | $0 |
| 2015 | 32,275 | $7,620,037 | 5,717,276 | $1,093,515,145 | 390,692 | $5,654,512 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-08 | 37,964,167 | $333,757,792 | 15,912 | $121,885 | 0 | $0 |
| 2025-06 | 6,352,667 | $35,870,765 | 0 | $0 | 0 | $0 |
| 2024-12 | 0 | $0 | 440 | $3,674 | 0 | $0 |
| 2024-09 | 0 | $0 | 13,370 | $83,027 | 0 | $0 |
| 2024-03 | 0 | $0 | 6,313 | $61,867 | 0 | $0 |
| 2023-12 | 0 | $0 | 220 | $1,623 | 0 | $0 |
| 2023-11 | 0 | $0 | 43 | $327 | 0 | $0 |
| 2023-09 | 0 | $0 | 6,685 | $55,351 | 0 | $0 |
| 2023-02 | 0 | $0 | 292 | $2,721 | 0 | $0 |
| 2022-05 | 0 | $0 | 0 | $0 | 427,854 | $0 |
| 2022-04 | 0 | $0 | 1,595 | $35,393 | 0 | $0 |
| 2022-03 | 0 | $0 | 27,745 | $639,320 | 0 | $0 |
| 2022-02 | 0 | $0 | 3,251 | $81,340 | 301,784 | $0 |
| 2022-01 | 0 | $0 | 3,251 | $86,574 | 0 | $0 |
| 2021-11 | 60,000 | $1,452,180 | 0 | $0 | 0 | $0 |
| 2021-08 | 11,400 | $286,436 | 0 | $0 | 0 | $0 |
| 2021-06 | 0 | $0 | 17,000 | $538,594 | 0 | $0 |
| 2021-05 | 0 | $0 | 11,037 | $350,811 | 0 | $0 |
| 2021-03 | 0 | $0 | 0 | $0 | 394,070 | $0 |
| 2020-12 | 0 | $0 | 114,055 | $2,266,386 | 114,055 | $1,640,110 |
| 2020-11 | 0 | $0 | 36,804 | $722,508 | 36,804 | $529,240 |
| 2020-09 | 0 | $0 | 5,667 | $91,635 | 0 | $0 |
| 2020-06 | 948,353 | $18,246,311 | 948,353 | $18,246,311 | 0 | $0 |
| 2020-05 | 5,000,000 | $83,212,731 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-21 | Lee Frank D. (Director) | Sale | 15,912 | 7.66 | 121,885 |
| 2025-08-14 | Paulson John | Buy | 34,721,118 | 9.00 | 312,490,062 |
| 2025-08-13 | Paulson John | Buy | 86,409 | 7.06 | 610,047 |
| 2025-08-12 | Paulson John | Buy | 1,156,640 | 6.88 | 7,957,683 |
| 2025-08-11 | Paulson John | Buy | 2,000,000 | 6.35 | 12,700,000 |
| 2025-06-13 | Paulson John | Buy | 3,564,059 | 5.94 | 21,170,510 |
| 2025-06-12 | Paulson John | Buy | 1,005,376 | 5.47 | 5,499,406 |
| 2025-06-11 | Paulson John | Buy | 1,029,098 | 5.24 | 5,392,473 |
| 2025-06-10 | Paulson John | Buy | 754,134 | 5.05 | 3,808,376 |
| 2024-12-02 | Carson Seana (EVP, General Counsel) | Sale | 440 | 8.35 | 3,674 |
| 2024-09-06 | Carson Seana (EVP, General Counsel) | Sale | 13,370 | 6.21 | 83,027 |
| 2024-03-04 | Carson Seana (EVP, General Counsel) | Sale | 6,313 | 9.80 | 61,867 |
| 2023-12-05 | Carson Seana (EVP, General Counsel) | Sale | 220 | 7.38 | 1,623 |
| 2023-11-06 | Carson Seana (EVP, General Counsel) | Sale | 43 | 7.61 | 327 |
| 2023-09-06 | Carson Seana (EVP, General Counsel) | Sale | 6,685 | 8.28 | 55,351 |
| 2023-02-28 | Carson Seana (EVP, General Counsel) | Sale | 292 | 9.32 | 2,721 |
| 2022-05-10 | Carson Seana (EVP, General Counsel) | Option Ex | 7,467 | .00 | 0 |
| 2022-05-10 | Appio Thomas (Chief Executive Officer) | Option Ex | 32,022 | .00 | 0 |
| 2022-05-10 | Spurr Robert (President, U.S. Businesses) | Option Ex | 22,235 | .00 | 0 |
| 2022-05-10 | Papa Joseph C (Director) | Option Ex | 366,130 | .00 | 0 |
| 2022-04-14 | Spurr Robert (U.S. President-Pharma Business) | Sale | 1,595 | 22.19 | 35,393 |
| 2022-03-15 | Spurr Robert (U.S. President-Pharma Business) | Sale | 4,846 | 22.20 | 107,581 |
| 2022-03-08 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Sale | 3,889 | 21.76 | 84,624 |
| 2022-03-02 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Sale | 11,077 | 23.37 | 258,869 |
| 2022-03-02 | Spurr Robert (U.S. President-Pharma Business) | Sale | 1,595 | 23.37 | 37,275 |
| 2022-03-01 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Sale | 6,338 | 23.82 | 150,971 |
| 2022-02-27 | Munsch Frederick (SVP, Controller and CAO) | Option Ex | 3,330 | .00 | 0 |
| 2022-02-27 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Option Ex | 17,350 | .00 | 0 |
| 2022-02-27 | Appio Thomas (CEO, Pharma Business) | Option Ex | 24,292 | .00 | 0 |
| 2022-02-27 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Option Ex | 24,292 | .00 | 0 |
| 2022-02-27 | Eldessouky Sam (EVP & Chief Financial Officer) | Option Ex | 8,674 | .00 | 0 |
| 2022-02-27 | Spurr Robert (U.S. President-Pharma Business) | Option Ex | 15,615 | .00 | 0 |
| 2022-02-27 | Papa Joseph C (Chairman & CEO) | Option Ex | 208,231 | .00 | 0 |
| 2022-02-15 | Spurr Robert (U.S. President-Pharma Business) | Sale | 3,251 | 25.02 | 81,340 |
| 2022-01-18 | Spurr Robert (U.S. President-Pharma Business) | Sale | 3,251 | 26.63 | 86,574 |
| 2021-11-30 | Miller Steven D (Director) | Buy | 60,000 | 24.20 | 1,452,180 |
| 2021-08-05 | Von Eschenbach Andrew C. (Director) | Buy | 1,400 | 25.94 | 36,316 |
| 2021-08-04 | De Schutter Richard U (Director) | Buy | 10,000 | 25.01 | 250,120 |
| 2021-06-11 | Eldessouky Sam (EVP & Chief Financial Officer) | Sale | 17,000 | 31.68 | 538,594 |
| 2021-05-26 | Wechsler Amy B (Director) | Sale | 11,037 | 31.79 | 350,811 |
| 2021-03-08 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Option Ex | 5,637 | .00 | 0 |
| 2021-03-08 | Appio Thomas (Pres&Co-Head Bausch&Lomb/Int'l) | Option Ex | 9,161 | .00 | 0 |
| 2021-03-08 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Option Ex | 8,455 | .00 | 0 |
| 2021-03-08 | Eldessouky Sam (SVP, CHIEF ACCOUNTING OFFICER) | Option Ex | 4,404 | .00 | 0 |
| 2021-03-08 | Herendeen Paul (EVP and CFO) | Option Ex | 49,324 | .00 | 0 |
| 2021-03-08 | Papa Joseph C (CHAIRMAN & CEO) | Option Ex | 317,089 | .00 | 0 |
| 2020-12-04 | Humphries William D. (President, Ortho-Dermatologics) | Sale | 114,055 | 19.87 | 2,266,386 |
| 2020-12-04 | Humphries William D. (President, Ortho-Dermatologics) | Option Ex | 114,055 | 14.38 | 1,640,110 |
| 2020-11-27 | Humphries William D. (President, Ortho-Dermatologics) | Sale | 13,663 | 19.63 | 268,204 |
| 2020-11-27 | Humphries William D. (President, Ortho-Dermatologics) | Option Ex | 13,663 | 14.38 | 196,473 |
| 2020-11-24 | Humphries William D. (President, Ortho-Dermatologics) | Sale | 21,658 | 19.63 | 425,189 |
| 2020-11-24 | Humphries William D. (President, Ortho-Dermatologics) | Option Ex | 21,658 | 14.38 | 311,442 |
| 2020-11-23 | Humphries William D. (President, Ortho-Dermatologics) | Sale | 1,483 | 19.63 | 29,115 |
| 2020-11-23 | Humphries William D. (President, Ortho-Dermatologics) | Option Ex | 1,483 | 14.38 | 21,325 |
| 2020-09-08 | Humphries William D. (President, Ortho-Dermatologics) | Sale | 5,667 | 16.17 | 91,635 |
| 2020-06-05 | Valueact Holdings Gp, Llc (Director) | Buy | 948,353 | 19.24 | 18,246,311 |
| 2020-06-05 | Valueact Holdings Gp, Llc (Director) | Sale | 948,353 | 19.24 | 18,246,311 |
| 2020-05-14 | Paulson John | Buy | 1,628,920 | 15.82 | 25,774,401 |
| 2020-05-13 | Paulson John | Buy | 1,330,044 | 16.53 | 21,989,617 |
| 2020-05-12 | Paulson John | Buy | 2,041,036 | 17.37 | 35,448,713 |
| 2020-03-12 | Ross Thomas W. Sr. (Director) | Buy | 2,500 | 15.54 | 38,837 |
| 2020-03-10 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Buy | 4,390 | 18.25 | 80,104 |
| 2020-03-10 | Von Eschenbach Andrew C. (Director) | Buy | 1,100 | 18.18 | 19,996 |
| 2020-03-10 | De Schutter Richard U (Director) | Buy | 3,800 | 18.26 | 69,376 |
| 2020-03-03 | De Schutter Richard U (Director) | Buy | 5,000 | 23.08 | 115,414 |
| 2020-02-19 | Gordon Joseph F (Pres&Co-Head Bausch&Lomb/Int'l) | Option Ex | 5,242 | .00 | 0 |
| 2020-02-19 | Appio Thomas (Pres&Co-Head Bausch&Lomb/Int'l) | Option Ex | 3,932 | .00 | 0 |
| 2020-02-19 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Option Ex | 7,864 | .00 | 0 |
| 2020-02-19 | Humphries William D. (President, Ortho-Dermatologics) | Option Ex | 20,911 | .00 | 0 |
| 2020-02-19 | Eldessouky Sam (SVP, CHIEF ACCOUNTING OFFICER) | Option Ex | 4,096 | .00 | 0 |
| 2019-09-13 | Papa Joseph C (CHAIRMAN & CEO) | Buy | 30,000 | 23.31 | 699,300 |
| 2019-08-19 | Mckenna Mark C. (President, Salix) | Sale | 10,773 | 21.83 | 235,217 |
| 2019-08-16 | Humphries William D. (President, Ortho-Dermatologics) | Buy | 30,703 | 21.18 | 650,136 |
| 2019-08-12 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Sale | 3,418 | 22.45 | 76,727 |
| 2019-07-11 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Sale | 3,968 | 24.81 | 98,446 |
| 2019-02-28 | Papa Joseph C (CHAIRMAN & CEO) | Buy | 30,000 | 23.67 | 710,100 |
| 2018-12-14 | Appio Thomas (Pres&Co-Head Bausch&Lomb/Int'l) | Buy | 25,440 | 22.96 | 584,026 |
| 2018-10-16 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Sale | 4,542 | 25.50 | 115,821 |
| 2018-10-15 | Ackermann Christina (EVP AND GENERAL COUNSEL) | Sale | 15,404 | 24.83 | 382,481 |
| 2018-09-14 | Herendeen Paul (EVP and CFO) | Buy | 10,000 | 22.61 | 226,100 |
| 2018-09-14 | Papa Joseph C (CHAIRMAN & CEO) | Buy | 30,000 | 22.32 | 669,600 |
| 2018-09-13 | De Schutter Richard U (Director) | Buy | 125,000 | 23.96 | 2,995,000 |
| 2018-05-15 | De Schutter Richard U (Director) | Buy | 25,000 | 21.81 | 545,450 |
| 2018-03-13 | Herendeen Paul (EVP and CFO) | Buy | 15,000 | 16.10 | 241,469 |
| 2018-03-13 | Papa Joseph C (CHAIRMAN & CEO) | Buy | 30,000 | 16.05 | 481,500 |
| 2018-03-08 | De Schutter Richard U (Director) | Buy | 10,000 | 15.34 | 153,400 |
| 2018-03-06 | Paulson John | Buy | 7,066,629 | 15.40 | 108,826,086 |
| 2018-03-06 | Paulson John | Sale | 7,066,629 | 15.40 | 108,826,086 |
| 2017-11-17 | De Schutter Richard U (Director) | Buy | 10,000 | 14.33 | 143,300 |
| 2017-11-16 | Paulson John | Buy | 344,216 | 14.40 | 4,955,677 |
| 2017-11-16 | Paulson John | Sale | 344,216 | 14.39 | 4,952,924 |
| 2017-08-21 | De Schutter Richard U (Director) | Buy | 10,000 | 14.33 | 143,300 |
| 2017-05-11 | De Schutter Richard U (Director) | Buy | 20,000 | 13.90 | 278,000 |
| 2017-03-15 | De Schutter Richard U (Director) | Buy | 10,000 | 10.80 | 108,000 |
| 2017-03-14 | Valueact Holdings Gp, Llc (Director) | Buy | 3,000,000 | 10.85 | 32,535,000 |
| 2017-03-14 | Herendeen Paul (EVP and CFO) | Buy | 24,000 | 10.72 | 257,280 |
| 2017-03-13 | Ackman William A (Director) | Sale | 18,114,432 | 11.00 | 199,258,752 |
| 2016-12-14 | Ross Thomas W. Sr. (Director) | Buy | 5,000 | 14.73 | 73,650 |
| 2016-12-12 | Ackman William A (Director) | Sale | 3,476,690 | 14.85 | 51,628,846 |
| 2016-08-11 | Karabelas Argeris N (Director) | Buy | 4,000 | 24.65 | 98,600 |
| 2016-06-13 | Ross Thomas W. Sr. (Director) | Buy | 4,000 | 24.40 | 97,600 |
| 2016-06-10 | Papa Joseph C (CHAIRMAN & CEO) | Buy | 202,000 | 24.48 | 4,944,960 |
| 2015-11-05 | Pearson J. Michael (Chief Executive Officer) | Sale | 1,297,399 | 78.53 | 101,884,743 |
| 2015-10-21 | Farmer Ronald Harold (Director) | Buy | 1,500 | 175.90 | 263,842 |
| 2015-08-26 | Farmer Ronald Harold (Director) | Buy | 500 | 220.00 | 110,000 |
| 2015-08-21 | Farmer Ronald Harold (Director) | Buy | 1,000 | 224.97 | 224,975 |
| 2015-07-31 | Rosiello Robert L. (EVP, Chief Financial Officer) | Buy | 704 | 257.25 | 181,104 |
| 2015-07-30 | Rosiello Robert L. (EVP, Chief Financial Officer) | Buy | 7,171 | 253.99 | 1,821,362 |
| 2015-06-12 | Rosiello Robert L. (Executive Vice President) | Buy | 12,900 | 232.51 | 2,999,379 |
| 2015-06-10 | Valueact Holdings Gp, Llc (Director) | Sale | 4,200,000 | 224.80 | 944,160,000 |
| 2015-06-09 | Farmer Ronald Harold (Director) | Buy | 500 | 232.05 | 116,025 |
| 2015-06-08 | Farmer Ronald Harold (Director) | Buy | 500 | 289.20 | 144,600 |
| 2015-06-02 | Mirovsky Pavel (EVP, Pres. & GM Valeant EMENA) | Sale | 37,900 | 237.99 | 9,019,896 |
| 2015-06-02 | Mirovsky Pavel (EVP, Pres. & GM Valeant EMENA) | Option Ex | 14,900 | 51.01 | 760,049 |
| 2015-06-01 | Mirovsky Pavel (EVP, Pres. & GM Valeant EMENA) | Sale | 100 | 240.00 | 24,000 |
| 2015-06-01 | Mirovsky Pavel (EVP, Pres. & GM Valeant EMENA) | Option Ex | 100 | 51.01 | 5,101 |
| 2015-05-26 | Whitaker Anne Clem (Director) | Buy | 7,500 | 234.50 | 1,758,750 |
| 2015-05-05 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Option Ex | 21,807 | 6.10 | 133,022 |
| 2015-05-04 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Sale | 90,938 | 222.54 | 20,237,433 |
| 2015-05-04 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Option Ex | 90,938 | 25.42 | 2,311,643 |
| 2015-05-01 | Stolz Brian M. (EVP, Administration & CHCO) | Option Ex | 3,675 | .00 | 0 |
| 2015-04-27 | Schiller Howard Bradley (Chief Financial Officer) | Option Ex | 22,500 | .00 | 0 |
| 2015-04-24 | Mirovsky Pavel (EVP, Pres. & GM Valeant EMENA) | Option Ex | 2,500 | .00 | 0 |
| 2015-04-17 | Kornwasser Laizer (EVP, Company Group Chairman) | Option Ex | 45,000 | .00 | 0 |
| 2015-04-15 | Mirovsky Pavel (President, EMENA) | Option Ex | 24,175 | .00 | 0 |
| 2015-03-03 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Option Ex | 21,808 | 6.10 | 133,028 |
| 2015-03-02 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Sale | 90,939 | 200.01 | 18,189,073 |
| 2015-03-02 | Chai-onn Robert Roswell (EVP, CLO, General Counsel) | Option Ex | 90,939 | 25.42 | 2,311,669 |
| 2015-01-22 | Stolz Brian M. (EVP, Administration and CHCO) | Option Ex | 7,350 | .00 | 0 |
| 2015-01-05 | Schiller Howard Bradley (EVP, Chief Financial Officer) | Option Ex | 45,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of BHC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Bausch Health Companies Inc. (symbol BHC, CIK number 885590) see the Securities and Exchange Commission (SEC) website.